1. 529 Gallstone Disease and the Risk of Cardiovascular Disease – a Mendelian Randomisation Study. (19th August 2022) Authors: Fairfield, C; Drake, T; Pius, R; Bretherick, A; Campbell, A; Clark, D; Fallowfield, J; Hayward, C; Henderson, N; Iakovliev, A; Joshi, P; Mills, N; Porteous, D; Ramachandran, P; Semple, R; Shaw, C; Sudlow, C; Timmers, P; Wilson, J; Wigmore, S Journal: British journal of surgery Issue: Volume 109(2022)Supplement 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inequalities in psychological distress before and during the COVID-19 pandemic among UK adults: Kishan Patel. (25th October 2022) Authors: Patel, K; Robertson, E; Kwong, ASF; Griffith, GJ; Willan, K; Green, MJ; Patalay, P; Porteous, D; Katikreddi, SV Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P96 Repeat Administration of GL67A/pGM169 is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses. (19th November 2012) Authors: Alton, EWFW; Boyd, AC; Cheng, SH; Davies, J; Davies, LA; Dayan, A; Gill, DR; Griesenbach, U; Higgins, T; Hyde, SC; Innes, A; McLachlan, G; Porteous, D; Pringle, IA; Scheule, RK; Sumner-Jones, SG Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S120 Update on the UK CF Gene Therapy Consortium Multidose, Non-Viral, Gene Therapy Trial. (19th November 2012) Authors: Alton, EWFW; Ashby, D; Boyd, C; Cheng, S; Cunningham, S; Davies, JC; Gill, D; Griesenbach, U; Higgins, T; Hyde, S; Innes, JA; Murray, G; Porteous, D Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗